#CBM Red Ink
06-Jul-89 09:04:27
Sb: #55903-#CBM Red Ink
Fm: Art Steinmetz 76044,3204
To: Gabe J. Feder 75470,2636
The problem seems to be manufacturing expenses are incurred in countries like
Taiwan where the currency is tied to the US dollar and most (~75%) of revenues
are in Europe, Germany in particular. A stronger dollar results in a margin
squeeze. While C='s announcement is news this relationship is not.
Sales volume abroad continues to go up, up, up. Fundementally the company is
in good shape. I think the stock is a screaming buy at 14.
If the strong dollar continues (Art sez it won't) a couple steps CBM could take
are moving more, or all, cost centers like R&D to where the revenues are –
Europe. OR they could concentrate on getting US revenues up to a bigger slice
of the pie. This latter step they've been working on for years without much
success (as we all know). — Art